Please login to the form below

Not currently logged in
Email:
Password:

Case Study

This page shows the latest Case Study news and features for those working in and with pharma, biotech and healthcare.

US Department of Health and Human Services calls for coronavirus product proposals

US Department of Health and Human Services calls for coronavirus product proposals

On the therapeutics front, the NIH has already initiated testing of Gilead’s anti-viral drug remdesivir in a phase 1 study in the US. ... Participants in the study must have a laboratory-confirmed case of the novel coronavirus as well as evidence of

Latest news

  • Raising awareness and encouraging support on Rare Disease Day 2020 Raising awareness and encouraging support on Rare Disease Day 2020

    One personal account for Rare Disease Day is a case study in which Dimitri Azzopardi explains what it is like to live with beta thalasseamia, a debilitating, life-long genetic blood

  • J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data J&J and Bristol-Myers Squibb/Bluebird bio reveal rival CAR-T data

    However, remissions in the study last on average for 10.6 months, and median progression-free survival was 8.6 months. ... The KarMMa study also had a case of patient death due to cytokine release syndrome as a side-effect of treatment with ide-cel

  • Amgen, Servier heart failure drug clears trial hurdle Amgen, Servier heart failure drug clears trial hurdle

    Amgen and Servier have inched closer to a verdict on their first-in-class chronic heart failure drug omecamtiv mecarbil, after their first phase 3 study passed a futility review. ... In the case of the GALACTIC-HF study of omecamtiv, the interim

  • Safety first: AI adoption in the healthcare sector Safety first: AI adoption in the healthcare sector

    The Royal Free London NHS Foundation Trust’s 2015 partnership with DeepMind is a case study of what can go wrong, despite the very best of intentions. ... Exit: provide for knowledge transfer services and exit support in the case of an unforeseen

  • London cancer hub launched by Cancer Research UK London cancer hub launched by Cancer Research UK

    CASE STUDY. Tanya Hill, 27, from Bedfordshire was diagnosed with B cell Acute Lymphoblastic Leukaemia (ALL) when she was 25. ... Tanya was then recruited onto the CARD trial, a clinical study of Chimeric Antigen Receptor (CAR) T cells to target ALL,

More from news
Approximately 0 fully matching, plus 117 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 3 fully matching, plus 90 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 23 fully matching, plus 77 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...

Infographics